| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M311224200 |
| P698 | PubMed publication ID | 15033992 |
| P50 | author | Zoe Johnson | Q57043911 |
| P2093 | author name string | Tracy M Handel | |
| Andreas J Kungl | |||
| Elena Geretti | |||
| Amanda E Proudfoot | |||
| Elaine K Lau | |||
| Frédéric Borlat | |||
| Chad D Paavola | |||
| Jean-Philippe Gaudry | |||
| P2860 | cites work | Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74 | Q22008605 |
| Aggregation of RANTES is responsible for its inflammatory properties. Characterization of nonaggregating, noninflammatory RANTES mutants | Q22010387 | ||
| Crystal structures of oligomeric forms of the IP-10/CXCL10 chemokine | Q27641187 | ||
| Crystal structure of recombinant human platelet factor 4 | Q27730824 | ||
| Heteronuclear (1H, 13C, 15N) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer | Q27732737 | ||
| The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions | Q27734322 | ||
| Calculation of protein extinction coefficients from amino acid sequence data | Q27861073 | ||
| The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity | Q28140341 | ||
| Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5 | Q28206239 | ||
| Human chemokines: an update | Q28237635 | ||
| HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines | Q28369641 | ||
| Chemokines and leukocyte traffic | Q29618886 | ||
| The biology of chemokines and their receptors | Q29619170 | ||
| Lymphocyte homing and homeostasis | Q29619924 | ||
| Multiple chemotactic factors: fine control or redundancy? | Q33633069 | ||
| The chemokine system: redundancy for robust outputs | Q33650445 | ||
| Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2. | Q33877707 | ||
| Identification of surface residues of the monocyte chemotactic protein 1 that affect signaling through the receptor CCR2. | Q33882772 | ||
| Heparin and heparan sulfate: biosynthesis, structure and function | Q33927046 | ||
| Structural diversity of heparan sulfate binding domains in chemokines | Q34008721 | ||
| Differential binding of chemokines to glycosaminoglycan subpopulations | Q34323127 | ||
| Emerging views of heparan sulfate glycosaminoglycan structure/activity relationships modulating dynamic biological functions | Q34536524 | ||
| Neutrophil activation by monomeric interleukin-8. | Q34662590 | ||
| Roles of heparan-sulphate glycosaminoglycans in cancer | Q34718195 | ||
| Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines | Q34762409 | ||
| Leukocyte extravasation: chemokine transport and presentation by the endothelium | Q34998445 | ||
| Chemokine receptors in inflammation: an overview | Q35048804 | ||
| Control of motility, exocytosis and the respiratory burst in human neutrophils | Q37725590 | ||
| Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites | Q38292569 | ||
| Identification of a glycosaminoglycan binding surface on human interleukin-8. | Q38334550 | ||
| A kinetics and modeling study of RANTES(9-68) binding to heparin reveals a mechanism of cooperative oligomerization | Q38359935 | ||
| The molecular biology of leukocyte chemoattractant receptors | Q40661169 | ||
| Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses | Q40925991 | ||
| Monomer complexes of basic fibroblast growth factor and heparan sulfate oligosaccharides are the minimal functional unit for cell activation | Q40957417 | ||
| Lysine 58 and histidine 66 at the C-terminal alpha-helix of monocyte chemoattractant protein-1 are essential for glycosaminoglycan binding | Q40999171 | ||
| Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans | Q41060711 | ||
| Chemokines have diverse abilities to form solid phase gradients | Q43564626 | ||
| Importance of basic residues and quaternary structure in the function of MIP-1 beta: CCR5 binding and cell surface sugar interactions | Q43577463 | ||
| Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B. | Q45999198 | ||
| Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes | Q47980599 | ||
| The Role of CD26/DPP IV in Chemokine Processing | Q56763495 | ||
| Glycosaminoglycans Mediate Cell Surface Oligomerization of Chemokines | Q57019212 | ||
| Transcytosis and Surface Presentation of IL-8 by Venular Endothelial Cells | Q57419171 | ||
| RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement | Q58038903 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 22294-22305 | |
| P577 | publication date | 2004-03-18 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo | |
| P478 | volume | 279 |
| Q38008721 | A beginner's guide to chemokines |
| Q38972454 | A combinatorial approach to biophysically characterise chemokine-glycan binding affinities for drug development |
| Q34363360 | A competitive binding study of chemokine, sulfated receptor, and glycosaminoglycan interactions by nano-electrospray ionization mass spectrometry |
| Q40374556 | A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs |
| Q50261941 | A three-dimensional in vitro model to demonstrate the haptotactic effect of monocyte chemoattractant protein-1 on atherosclerosis-associated monocyte migration. |
| Q36661058 | Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection. |
| Q41789851 | An Ion Mobility-Mass Spectrometry Investigation of Monocyte Chemoattractant Protein-1. |
| Q36882279 | An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo. |
| Q33425955 | Astrocyte- and endothelial-targeted CCL2 conditional knockout mice: critical tools for studying the pathogenesis of neuroinflammation |
| Q38333725 | Biologically Relevant Metal-Cation Binding Induces Conformational Changes in Heparin Oligosaccharides as Measured by Ion Mobility Mass Spectrometry |
| Q34528303 | Breast cancer: coordinated regulation of CCL2 secretion by intracellular glycosaminoglycans and chemokine motifs |
| Q37698743 | CCL2 nitration is a negative regulator of chemokine-mediated inflammation. |
| Q40261698 | CCL5-CCR5-mediated apoptosis in T cells: Requirement for glycosaminoglycan binding and CCL5 aggregation |
| Q33289106 | CCR2 chemokines bind selectively to acetylated heparan sulfate octasaccharides |
| Q39975348 | Chapter 2. Homo- and hetero-oligomerization of chemokines |
| Q46176996 | Chapter 4. Interactions of chemokines with glycosaminoglycans |
| Q28285739 | Characterization of molecular interactions between eosinophil cationic protein and heparin |
| Q33885243 | Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycans. |
| Q38341658 | Characterization of the interactions of vMIP-II, and a dimeric variant of vMIP-II, with glycosaminoglycans |
| Q35528569 | Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies |
| Q37827607 | Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function |
| Q37608845 | Chemokine oligomerization in cell signaling and migration |
| Q37349685 | Chemokine receptor antagonists: overcoming developmental hurdles |
| Q33810517 | Chemokine receptor oligomerization and allostery |
| Q30857874 | Chemokine-glycosaminoglycan binding: specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry |
| Q35925887 | Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins |
| Q36918688 | Chemokines: novel targets for breast cancer metastasis |
| Q36488894 | Clinical utilization of chemokines to combat cancer: the double-edged sword |
| Q35611323 | Crystal structure of a mirror-image L-RNA aptamer (Spiegelmer) in complex with the natural L-protein target CCL2. |
| Q38194193 | Demystifying heparan sulfate-protein interactions. |
| Q55173831 | Designing a mutant CCL2-HSA chimera with high glycosaminoglycan-binding affinity and selectivity |
| Q37637122 | Differential structural remodelling of heparan sulfate by chemokines: the role of chemokine oligomerization. |
| Q27649259 | Dual GPCR and GAG mimicry by the M3 chemokine decoy receptor |
| Q84743284 | Effect of the C-terminal domain peptide fragment (65-76) of monocytic chemotactic protein-1 (MCP-1) on the interaction between MCP-1 and heparin |
| Q33245170 | Effects of sulfate position on heparin octasaccharide binding to CCL2 examined by tandem mass spectrometry |
| Q36642385 | Examination of Glycosaminoglycan Binding Sites on the XCL1 Dimer |
| Q30568524 | Fell-Muir Lecture: Heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra |
| Q42366882 | Glycosaminoglycan Interactions with Chemokines Add Complexity to a Complex System |
| Q36321143 | Glycosaminoglycan analogs as a novel anti-inflammatory strategy |
| Q47327922 | Glycosaminoglycan-Mediated Downstream Signaling of CXCL8 Binding to Endothelial Cells |
| Q38287875 | Heparan Sulfate Microarray Reveals That Heparan Sulfate-Protein Binding Exhibits Different Ligand Requirements |
| Q92290210 | Heparin Binding Proteins as Therapeutic Target: An Historical Account and Current Trends |
| Q42172490 | Heparin alters viral serpin, serp-1, anti-thrombolytic activity to anti-thrombotic activity. |
| Q42230430 | Heparin-immobilized microspheres for the capture of cytokines |
| Q38418286 | Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use. |
| Q92152542 | Heparinoid Complex-Based Heparin-Binding Cytokines and Cell Delivery Carriers |
| Q36403611 | Identification of proteoglycans as the APRIL-specific binding partners. |
| Q28571882 | In vitro and in vivo affinity microdialysis sampling of cytokines using heparin-immobilized microspheres |
| Q35626866 | In-vitro suppression of IL-6 and IL-8 release from human pulmonary epithelial cells by non-anticoagulant fraction of enoxaparin |
| Q36194268 | Inactivation of heparan sulfate 2-O-sulfotransferase accentuates neutrophil infiltration during acute inflammation in mice. |
| Q80067132 | Inhibition of migration of monocytes and granulocytes in vivo by the peptide corresponding to sequence 65-76 of monocyte chemotactic protein-1 (MCP-1) |
| Q39150057 | Interaction of endothelial cells with macrophages-linking molecular and metabolic signaling |
| Q34004904 | Interference with glycosaminoglycan-chemokine interactions with a probe to alter leukocyte recruitment and inflammation in vivo. |
| Q42064793 | Ion mobility mass spectrometry coupled with rapid protein threading predictor structure prediction and collision-induced dissociation for probing chemokine conformation and stability |
| Q36920584 | MCP-1 binds to oxidized LDL and is carried by lipoprotein(a) in human plasma |
| Q28505465 | Molecular mapping and functional characterization of the VEGF164 heparin-binding domain |
| Q36222092 | Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes |
| Q37890185 | Monocyte and macrophage dynamics during atherogenesis |
| Q38139823 | Monocyte chemoattractant protein-1 and the blood-brain barrier |
| Q37396582 | Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes. |
| Q34065898 | Monocyte-mediated defense against microbial pathogens. |
| Q35085550 | Mouse MCP1 C-terminus inhibits human MCP1-induced chemotaxis and BBB compromise |
| Q38965249 | Mouse monocyte chemoattractant protein 1 (MCP1) functions as a monomer |
| Q33652172 | Multiple glycosaminoglycan-binding epitopes of monocyte chemoattractant protein-3/CCL7 enable it to function as a non-oligomerizing chemokine |
| Q27660108 | NMR Analysis of the Structure, Dynamics, and Unique Oligomerization Properties of the Chemokine CCL27 |
| Q38815332 | New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model. |
| Q38081956 | New targets for glycosaminoglycans and glycosaminoglycans as novel targets. |
| Q27671636 | Oligomeric Structure of the Chemokine CCL5/RANTES from NMR, MS, and SAXS Data |
| Q43010856 | Oligomerized, filamentous surface presentation of RANTES/CCL5 on vascular endothelial cells |
| Q31108883 | Peripheral blood cell signatures of Plasmodium falciparum infection during pregnancy |
| Q37893687 | Pharmacological modulation of chemokine receptor function. |
| Q39385980 | Properties of 7ND-CCL2 are modulated upon fusion to Fc. |
| Q47719302 | Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection |
| Q37760881 | Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection |
| Q39615447 | Rationally evolving MCP-1/CCL2 into a decoy protein with potent anti-inflammatory activity in vivo |
| Q39068689 | Rodent herpesvirus Peru encodes a secreted chemokine decoy receptor |
| Q38114832 | Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases |
| Q41774423 | Site-directed mutagenesis of the CC chemokine binding protein 35K-Fc reveals residues essential for activity and mutations that increase the potency of CC chemokine blockade |
| Q33649788 | Structural Evidence for the Tetrameric Assembly of Chemokine CCL11 and the Glycosaminoglycan Arixtra™ |
| Q34579372 | Structural NMR of protein oligomers using hybrid methods |
| Q27643703 | Structural and Functional Basis of CXCL12 (Stromal Cell-derived Factor-1 ) Binding to Heparin |
| Q38022773 | Structure-based design of decoy chemokines as a way to explore the pharmacological potential of glycosaminoglycans. |
| Q80238245 | Surface-bound chemokines capture and prime T cells for synapse formation |
| Q84535196 | Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting |
| Q91973506 | Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation |
| Q34374614 | The "CPC clip motif": a conserved structural signature for heparin-binding proteins |
| Q28115376 | The Anti-inflammatory Protein TSG-6 Regulates Chemokine Function by Inhibiting Chemokine/Glycosaminoglycan Interactions |
| Q34181442 | The C Terminus of Mouse Monocyte Chemoattractant Protein 1 (MCP1) Mediates MCP1 Dimerization while Blocking Its Chemotactic Potency |
| Q47207922 | The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies. |
| Q49178749 | The Role of miR-126 in Critical Limb Ischemia Treatment Using Adipose-Derived Stem Cell Therapeutic Factor Concentrate and Extracellular Matrix Microparticles |
| Q33836880 | The antimicrobial activity of CCL28 is dependent on C-terminal positively-charged amino acids |
| Q36530735 | The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization |
| Q36038807 | The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions. |
| Q43058079 | The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin |
| Q82230494 | The peptide of sequence 66-77 of monocytic chemotactic protein (MCP-1) inhibits inflammation in experimental animals |
| Q38678399 | The sweet spot: how GAGs help chemokines guide migrating cells |
| Q40232348 | Two glycosaminoglycan-binding domains of the mouse cytomegalovirus-encoded chemokine MCK-2 are critical for oligomerization of the full-length protein |
| Q38680670 | What Do Structures Tell Us About Chemokine Receptor Function and Antagonism? |
Search more.